First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.

Daccord, Cécile; Letovanec, Igor; Yerly, Patrick; Bloch, Jonathan; Ogna, Adam; Nicod, Laurent P; Aubert, John-David

Daccord, Cécile; Letovanec, Igor; Yerly, Patrick; Bloch, Jonathan; Ogna, Adam; Nicod, Laurent P; Aubert, John-David.

Afiliación

Daccord C; Dept of Respiratory Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Letovanec I; Dept of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Yerly P; Dept of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.
Bloch J; Service and Central Laboratory of Hematology, Oncology Dept, Lausanne University Hospital, Lausanne, Switzerland.
Ogna A; Dept of Respiratory Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Nicod LP; Dept of Respiratory Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Aubert JD; Lung Transplantation Unit, Lausanne University Hospital, Lausanne, Switzerland.

Eur Respir J ; 51(3)2018 03.

Article en En | MEDLINE | ID: mdl-29348153

Asunto(s)

Dasatinib; Arteria Pulmonar; Humanos; Hipertensión Pulmonar; Circulación Pulmonar; Enfermedades Vasculares

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Arteria Pulmonar / Dasatinib Límite: Humans Idioma: En Revista: Eur Respir J Año: 2018 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google